Trial Number

547-25

Condition

Head & Neck Cancer

Participant Age Range

18 Years to 130 Years

Participant Gender

Any

Enrolling Participants

Yes

Overview

“A Phase III, Randomized, Open-Label, Multi-Center, Global Study of Volrustomig (MEDI5752) as Sequential Therapy Versus Observation in Participants with Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma, Who Have Not Progressed Following Definitive Concurrent Chemoradiotherapy(eVOLVE-HNSCC)”

The main purpose of this study is to measure the efficacy and safety of volrustomig compared to observation in unresected LA-HNSCC participants who have not progressed following definitive cCRT.

Provider

Cancer Institute

Amol H Rao, MD

Hematology-Oncology, Hematology/Oncology
Fountain Valley
View Profile

Location

Orange Coast Medical Center

18111 Brookhurst Street
Fountain Valley
714-378-7000
Location Details

Related Clinical Trials

Click on the category you are interested in.

Cancer Care Orange Coast Medical Center
Name
Enter Trial number from the area just below the marquee.
How would you prefer to be contacted?
How did you hear about us?
This registration is for:
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.